White Paper

Micro-Flow Imaging Enables Cutting Edge Biopharmaceutical Research

Source: bio-techne
Bio Techne MFI

WHY YOUR RESEARCH MATTERS TO US

Protein aggregation and the formation of subvisible particles can significantly impact the safety and efficacy of biopharmaceuticals. Therefore, protein aggregation and subvisible particle content must be carefully monitored during in-process and final product development. ProteinSimple offers Micro-Flow Imaging™ (MFI), a powerful system to analyze protein aggregates and other subvisible particles in your samples. MFI combines the direct imaging capabilities of digital microscopy with the precise control of microfluidics. This allows for high-resolution images with 85% sampling efficiency, and precise counts and sizing with full morphological detail for all sub-visible particles in your sample, including protein aggregates, silicone micro-droplets, air bubbles, and more. MFI also includes automated sampling to analyze up to ~90 samples without user intervention.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: